Uterine fibroids, a common benign tumor in the female reproductive system, tend to occur in middle-aged women, most patients have no obvious symptoms and do not need to be treated, but some patients show increased menstrual flow with blood clots, and some rings show pressure on the bladder due to large fibroids, with frequent urination, urinary urgency, and even urinary retention, and very few patients can develop malignancy, and these patients need active treatment These patients need active management and treatment. Interventional embolization for uterine fibroids is to artificially embolize the end vessels of the blood supply to the fibroids by pushing a certain size and amount of embolic pellets through the catheter to cut off the blood supply to the fibroids directly, so that the fibroids will become ischemic and necrotic, and then gradually shrink, thus achieving the effect of reducing the fibroids and alleviating the symptoms of pressure caused by the fibroids, such as urinary frequency, urinary urgency and constipation. The result is a reduction in fibroids and a reduction in symptoms such as urinary frequency, urinary urgency and constipation. As the endometrial blood supply is also affected by uterine artery embolization, the menstrual blood volume will be reduced to a certain extent during menstruation, and the anemia caused by fibroids will be improved accordingly. Interventional embolization for uterine fibroids is effective for patients with all types of fibroids, but it is still not possible for patients with poor basic physical condition, such as the occurrence of severe liver and kidney function damage, serious cardiovascular and cerebrovascular diseases, coagulation mechanism disorders, allergy to contrast agents and anesthetics, etc. Therefore, although interventional surgery is simpler and easier to perform than traditional myomectomy, routine blood, coagulation, liver and kidney function, electrocardiogram and other related tests are still required to ensure the safety of the procedure.